Cost of poor adherence to anti-hypertensive therapy in five European countries

Overview of attention for article published in HEPAC Health Economics in Prevention and Care, January 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 31,919 followers.

RT @AETSA_ #Coste de la baja adherencia a terapia #antihipertensiva en 5 países europeos http://t.co/HXc6vCKv3A Indirecta pero impactante

RT @AETSA_ #Coste de la baja adherencia a terapia #antihipertensiva en 5 países europeos http://t.co/HXc6vCKv3A Indirecta pero impactante

RT @AETSA_ #Coste de la baja adherencia a terapia #antihipertensiva en 5 países europeos http://t.co/HXc6vCKv3A Indirecta pero impactante

Study: 'Cost of poor adherence to anti-hypertensive therapy in five European countries' http://t.co/8tni7ujHHF

#HealthEconJA Cost of poor adherence to anti-hypertensive therapy in five European countries http://t.co/O8J2DdTzrL